Prosta Fink Forte® in the Therapy of Benign Prostatic Hyperplasia. Multicentric Surveillance Study in 2,245 Patients

Author(s): Theurer, C., Schiebel-Schlosser, G.

Abstract: Objective and Design: Therapeutic use and safety of a pump kin seed extract were tested in a multicentric clinical trial. Patients and Methods: 2,245 patients suffering from benign prostate hyperplasia (stage I to II according to Alken) received for 12 weeks 1-2 capsules Prosta Fink Forte per day. Urinary symptoms were recorded by the International Prostate Symptom Score according to the American Urological Association (I-PSS), the influence an quality of life has been recorded by a quality of life questionnaire (LQ Index). Results: The I-PSS decreased by 41.4%, life quality improved by 46.1% during therapy. More than 96% of the patients reported no undesired side effects under the treatment with Prosta Fink Forte. Conclusion: Prosta Fink Forte facilitates an efficient improvement of BPH symptoms, especially in early stages.

Keyword(s): Cucurbita pepo

Zurück | Weiter